May 2011 to 2000 Customer Service Representative, tech specialistShentel management company Hagerstown, MD Jun 2008 to 2011 Retail Sales Representative
Education:
North Hagerstown high school Hagerstown, MD 2003 to 2007 High diploma
Name / Title
Company / Classification
Phones & Addresses
Andrea Leonard Owner
Sherwood Homebuilding & Renovations Contractors - General. Home Improvements
120-39235 C & E Trail, Red Deer County, AB T4S 2P7 4033926252
Andrea Leonard Owner
Sherwood Homebuilding & Renovations Contractors - General · Home Improvements
But exercising during or after breast cancer treatments has many benefits, such as improving tolerance to treatments, increasing energy, reducing pain and preventing and managing lymphedema, says Andrea Leonard, president of the Cancer Exercise Training Institute in Portland, Ore., and author of Es
Date: Sep 18, 2013
Category: Health
Source: Google
Asthma Inhaler Primatene Mist Going Off the Market
is phase-out, all of the other inhalers that could substitute for the CFC over-the-counter inhaler to relieve symptoms of mild asthma require a prescription, Dr. Andrea Leonard-Segal, director of the FDAs Division of Nonprescription Clinical Evaluation, said during a morning news conference.SOURCE: Sept. 22, 2011, teleconference with: Andrea Leonard-Segal, M.D., director, Division of Nonprescription Clinical Evaluation, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Date: Sep 23, 2011
Category: Health
Source: Google
FDA to Primatene Users: Get Asthma Prescription Now
"All inhalers that might substitute require a prescription," the FDA's Andrea Leonard-Segal, MD, said at a news teleconference. "So those who use Primatene need to take action now to see a health care provider to get a replacement product." Leonard-Segal is the director of the FDA's division of nonp
Physicians should start asking all patients with asthma if they use the product and, if so, talk to them about prescription inhalers that can be used instead for short-term symptom relief, said Andrea Leonard-Segal, MD, of the FDA's nonprescription drugs unit, on a conference call with reporters.